Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial

by Moscetti, Luca, Fabbri, Maria Agnese, Natoli, Clara, Vici, Patrizia, Gamucci, Teresa, Sperduti, Isabella, Iezzi, Laura, Iattoni, Elena, Pizzuti, Laura, Roma, Carmine, Vaccaro, Angela, D’Auria, Giuliana, Mauri, Mariella, Mentuccia, Lucia, Grassadonia, Antonino, Barba, Maddalena, Ruggeri, Enzo Maria
Published in Oncotarget (2017)

The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 Lockdown

by Fabi, Alessandra, Pugliese, Patrizia, Falbo, Pina Tiziana, Corsi, Domenico, Fabbri, Maria Agnese, Vincenzi, Bruno, Bria, Emilio, Angelini, Francesco, Bonucci, Alessandro, Pellegrino, Arianna, Falcicchio, Chiara, Caruso, Anita, Giacomelli, Luca, Mirisola, Valentina, Papa, Simonetta, Cognetti, Francesco, Ciliberto, Gennaro, Perrone, Maria
Published in Cancers (Basel) (2020)

PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy

by Cognetti, Francesco, Masetti, Riccardo, Fabi, Alessandra, Bianchi, Giulia, Santini, Donatella, Rognone, Alessia, Catania, Giovanna, Angelucci, Domenico, Naso, Giuseppe, Giuliano, Mario, Vassalli, Lucia, Vici, Patrizia, Scognamiglio, Giovanni, Generali, Daniele, Zambelli, Alberto, Colleoni, Marco, Tinterri, Corrado, Scanzi, Francesco, Vigna, Leonardo, Scavina, Paola, Gamucci, Teresa, Marrazzo, Emilia, Scinto, Angelo Fedele, Berardi, Rossana, Fabbri, Maria Agnese, Pinotti, Graziella, Franco, Daniela, Terribile, Daniela Andreina, Tonini, Giuseppe, Cianniello, Daniela, Barni, Sandro
Published in NPJ Breast Cancer (2021)

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab

by Pizzuti, Laura, Sergi, Domenico, Sperduti, Isabella, Lauro, Luigi Di, Mazzotta, Marco, Botti, Claudio, Izzo, Fiorentino, Marchetti, Luca, Tomao, Silverio, Marchetti, Paolo, Natoli, Clara, Grassadonia, Antonino, Gamucci, Teresa, Mentuccia, Lucia, Magnolfi, Emanuela, Vaccaro, Angela, Cassano, Alessandra, Rossi, Ernesto, Botticelli, Andrea, Sini, Valentina, Sarobba, Maria G, Fabbri, Maria Agnese, Moscetti, Luca, Astone, Antonio, Michelotti, Andrea, De Angelis, Claudia, Bertolini, Ilaria, Angelini, Francesco, Ciliberto, Gennaro, Maugeri-Saccà, Marcello, Giordano, Antonio, Barba, Maddalena, Vici, Patrizia
Published in Cancer Biol Ther (2018)

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

by Gamucci, Teresa, Pizzuti, Laura, Natoli, Clara, Mentuccia, Lucia, Sperduti, Isabella, Barba, Maddalena, Sergi, Domenico, Iezzi, Laura, Maugeri-Saccà, Marcello, Vaccaro, Angela, Magnolfi, Emanuela, Gelibter, Alain, Barchiesi, Giacomo, Magri, Valentina, D’Onofrio, Loretta, Cassano, Alessandra, Rossi, Ernesto, Botticelli, Andrea, Moscetti, Luca, Omarini, Claudia, Fabbri, Maria Agnese, Scinto, Angelo Fedele, Corsi, Domenico, Carbognin, Luisa, Mazzotta, Marco, Bria, Emilio, Foglietta, Jennifer, Samaritani, Riccardo, Garufi, Carlo, Mariani, Luciano, Barni, Sandro, Mirabelli, Rosanna, Sarmiento, Roberta, Graziano, Vincenzo, Santini, Daniele, Marchetti, Paolo, Tonini, Giuseppe, Di Lauro, Luigi, Sanguineti, Giuseppe, Paoletti, Giancarlo, Tomao, Silverio, De Maria, Ruggero, Veltri, Enzo, Paris, Ida, Giotta, Francesco, Latorre, Agnese, Giordano, Antonio, Ciliberto, Gennaro, Vici, Patrizia
Published in Cancer Biol Ther (2018)

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

by Bon, Giulia, Pizzuti, Laura, Laquintana, Valentina, Loria, Rossella, Porru, Manuela, Marchiò, Caterina, Krasniqi, Eriseld, Barba, Maddalena, Maugeri-Saccà, Marcello, Gamucci, Teresa, Berardi, Rossana, Livi, Lorenzo, Ficorella, Corrado, Natoli, Clara, Cortesi, Enrico, Generali, Daniele, La Verde, Nicla, Cassano, Alessandra, Bria, Emilio, Moscetti, Luca, Michelotti, Andrea, Adamo, Vincenzo, Zamagni, Claudio, Tonini, Giuseppe, Barchiesi, Giacomo, Mazzotta, Marco, Marinelli, Daniele, Tomao, Silverio, Marchetti, Paolo, Valerio, Maria Rosaria, Mirabelli, Rosanna, Russo, Antonio, Fabbri, Maria Agnese, D’Ostilio, Nicola, Veltri, Enzo, Corsi, Domenico, Garrone, Ornella, Paris, Ida, Sarobba, Giuseppina, Giotta, Francesco, Garufi, Carlo, Cazzaniga, Marina, Del Medico, Pietro, Roselli, Mario, Sanguineti, Giuseppe, Sperduti, Isabella, Sapino, Anna, De Maria, Ruggero, Leonetti, Carlo, Di Leo, Angelo, Ciliberto, Gennaro, Falcioni, Rita, Vici, Patrizia
Published in J Exp Clin Cancer Res (2020)

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

by Pizzuti, Laura, Barba, Maddalena, Mazzotta, Marco, Krasniqi, Eriseld, Maugeri-Saccà, Marcello, Gamucci, Teresa, Berardi, Rossana, Livi, Lorenzo, Ficorella, Corrado, Natoli, Clara, Cortesi, Enrico, Generali, Daniele, La Verde, Nicla, Cassano, Alessandra, Bria, Emilio, Moscetti, Luca, Michelotti, Andrea, Adamo, Vincenzo, Zamagni, Claudio, Tonini, Giuseppe, Sergi, Domenico, Marinelli, Daniele, Paoletti, Giancarlo, Tomao, Silverio, Botticelli, Andrea, Marchetti, Paolo, Tinari, Nicola, Grassadonia, Antonino, Valerio, Maria Rosaria, Mirabelli, Rosanna, Fabbri, Maria Agnese, D’Ostilio, Nicola, Veltri, Enzo, Corsi, Domenico, Garrone, Ornella, Paris, Ida, Sarobba, Giuseppina, Meattini, Icro, Pistelli, Mirco, Giotta, Francesco, Lorusso, Vito, Garufi, Carlo, Russo, Antonio, Cazzaniga, Marina, Del Medico, Pietro, Roselli, Mario, Vaccaro, Angela, Perracchio, Letizia, di Benedetto, Anna, Daralioti, Theodora, Sperduti, Isabella, De Maria, Ruggero, Di Leo, Angelo, Sanguineti, Giuseppe, Ciliberto, Gennaro, Vici, Patrizia
Published in Sci Rep (2021)